U.S. market Closed. Opens in 17 hours 24 minutes

DTIL | Precision BioSciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue48.73M25.10M115.53M24.29M22.24M10.88M6.48M7.01M
Cost of Revenue8.26M9.00MN/AN/AN/AN/AN/AN/A
Gross Profit40.47M16.09M115.53M24.29M22.24M10.88M6.48M7.01M
Operating Expenses92.46M125.46M154.93M134.11M109.44M58.80M28.34M15.20M
Selling, General & Admin39.09M41.52M39.69M36.05M27.03M13.67M8.02M6.10M
Research & Development53.38M83.94M115.24M98.06M82.42M45.12M20.32M9.10M
Other Operating ExpensesN/AN/AN/AN/A-9.76MN/AN/AN/A
Operating Income-43.74M-100.37M-39.40M-109.83M-87.20M-47.91M-21.97M-8.83M
Other Expenses / Income1.21M27.46M8.80M822.00K-5.67M1.88M872.00K572.00K
Before Tax Income-42.53M-111.64M-30.60M-109.01M-92.88M-46.04M-21.10M-8.26M
Income Tax ExpensesN/A11.27M316.00K10.43M-9.58M1.88M-754.00K-5.00K
Net Income-61.32M-122.91M-30.92M-109.01M-83.30M-46.04M-21.10M-8.25M
Interest Expenses2.23M1.11M132.00KN/A182.00KN/AN/AN/A
Basic Shares Outstanding3.84M2.93M1.96M1.73M1.40M1.63M1.12M1.67B
Diluted Shares Outstanding3.84M2.93M1.96M1.73M1.40M1.63M1.12M1.67B
EBITDA-32.04M-62.79M-20.27M-99.19M-87.38M-43.68M-20.42M-8.19M
EBITDA Margin-65.76%-250.20%-17.55%-408.45%-392.92%-401.39%-314.94%-116.72%
EBIT-59.09M-110.53M-30.47M-98.58M-92.69M-44.16M-21.86M-8.26M
EBIT Margin-121.27%-440.38%-26.37%-405.92%-416.83%-405.79%-337.08%-117.69%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙